Scientists Discover a Promising New Target for Diabetes Treatment
Research group has found a promising molecular target for beta cell protection and regeneration therapy that does not carry the unintended side effects of intensive insulin therapy
29-Jan-2021 -
Researchers have discovered a novel and druggable insulin inhibitory receptor, named inceptor. The latest study from Helmholtz Zentrum München, the Technical University of Munich and the German Center for Diabetes Research is a significant milestone for diabetes research as the scientific ...
beta cells
diabetes
diabetes mellitus
+2